Bristol-Myers Squibb Announces European Commission Approval of Pending Acquisition of Celgene
NEW YORK–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced that the European Commission (EC) has granted unconditional approval of Bristol-Myers…